Abstract This study aims to investigate the signaling mechanism involved in HS-induced modulation of adenosine-mediated vascular tone in the presence or absence of adenosine A 2A receptor (A 2A AR). We hypothesized that HS-induced enhanced vascular relaxation through A 2A AR and epoxyeicosatrienoic acid (EETs) is dependent on peroxisome proliferator-activated receptor gamma (PPARc) and ATP-sensitive potassium channels (K ATP channels) in A 2A AR
Introduction
Adenosine, an endogenous nucleoside, is generally cytoprotective in nature and produced in response to stressful conditions. Adenosine mediates its effects via four adenosine receptors: A 1 , A 2A , A 2B , and A 3 [1] . Among many stressful conditions such as ischemia, hypoxia, injury, and inflammation, exposure to high salt (HS) diet has also been shown to elevate the generation of adenosine [2, 3] . Growing evidence suggests a link between high dietary salt intake and activation of adenosine receptors and A 2A receptor in particular [4] [5] [6] . In response to salt loading, enhanced vasodilation has been reported to occur through A 2A AR [4] [5] [6] [7] [8] .
HS-induced A 2A AR-mediated vasodilation is dependent on epoxyeicosatrienoic acid (EETs) generation through enhanced cyp-epoxygenase activity [6, 9, 10] . Studies from our lab and others have found that compared to normal salt (NS), HS diet-fed mouse aortae produced enhanced vascular relaxation to selective adenosine A 2A receptor agonist (CGS-21680), and this enhanced dilation was blunted by cyp-epoxygenases inhibitor, methylsulfonyl-propargyloxyphenylhexanamide (MSPPOH) [5] , and also by EETs antagonist (14,15 EEZE) [11] . EETs are 20-carbon fatty acid derived from the metabolism of arachidonic acid (AA) by cytochrome P450 epoxygenases (CYPs). The cellular levels of EETs depend not only on their production by CYPs but also on hydrolysis to dihydroxyeicosatrienoic acids (DHETs) by soluble epoxide hydrolase (sEH) [12] . Inhibiting or deleting sEH has become an important approach to increase the level of EETs that cause reduction in blood pressure in mice [13, 14] . Many effects exerted by EETs overlap with adenosine function including regulation of vascular tone, inflammation, proliferation, platelet aggregation, and cardiac function [15] [16] [17] . The receptors for EETs are, however, poorly understood. EETs receptors have not been identified and cloned yet, and the mechanism by which EETs mediate their effects is largely unknown. However, there is some evidence suggesting that EETs act through receptors, and some studies suggest that EETs have affinity to already known binding sites and receptors [18] [19] [20] .
Report showing that EETs specifically bind to the plasma membrane of human U937-transformed monocytes [19] indicates the presence of EETs receptor. Given its pleiotropic effects, EETs may act through number of different receptors.
Many of the long-term actions of the epoxygenases pathways are common to PPARs activation. Activation of PPARs, similar to effect of EETs, causes regulation of vascular tone, vascular cell proliferation, migration, and inflammation [21, 22] . Proposed endogenous PPAR ligands have originated from AA and linoleic acid metabolism, among which possible ligands could be produced by epoxygenases pathway. Few studies have been conducted to examine the possible candidacy of epoxygenase-derived metabolites as PPAR ligands. Cyp4a metabolite of EETs has been reported to be high affinity PPAR ligands [23, 24] . Also, EETs protect against angII-induced abdominal aneurysm in cyp2j2-overexpressed mice through PPARc [25] . In addition, EETs-induced angiogenesis in endothelial progenitor cells in patients with acute myocardial infarction is demonstrated to be dependent on PPARc [26] . Liu et al. reported that PPARc antagonist (GW9662) blocked EETs/AUDA-mediated anti-inflammatory effects [27] , suggesting that PPARc is an effector of EETs. The EETs-PPARc pathway may therefore represent a novel endogenous pathway by which transitory lipid mediators control vascular cell function. Henceforth, it would be interesting to evaluate the role of PPARc on A 2A AR-EETsmediated regulation of vascular tone in HS and NS-fed mice.
The peroxisome proliferator-activated receptors (PPARs) are ligand activated transcriptional factors belonging to the family of three (a, b/d, c) nuclear receptors that are activated by lipid metabolites and play a critical role in glucose homeostasis and lipid metabolism. PPARs have the ability to bind to large number of ligands mainly because of their large ligand-binding domain [28, 29] . Accumulating evidence suggests that PPARc contributes in regulation of vascular function and blood pressure in addition to its well-recognized role in adipogenesis and insulin sensitivity. Thiazolidinedione (TZD), specific PPARc ligands, has been reported to lower blood pressure and provide cardiovascular benefits through regulating vascular function and vascular tone [30] . Studies have demonstrated that PPARc activation elicits relaxation in pulmonary arteries by activating K ATP channels through unknown mechanism [31] .
It is interesting that activation of PPARc, similar to effects of A 2A AR and EETs, causes vasodilation, anti-inflammation, and anti-proliferation. To our interest, it is evident that A 2A AR and EETs are involved in HS-induced vascular relaxation; however, information regarding the role of PPARc and K ATP channels is lacking. Here in this study, the role of PPARc and K ATP channels in HS-induced A 2A AR-mediated vascular relaxation and the interplay between A 2A AR, EETs, and sEH in the regulation of vascular tone are explored using HS and NS-fed A 2A AR
and A 2A AR -/-mice.
Materials and methods
The experimental and animal care protocols used in this study were approved by the West Virginia University In- and A 2A AR -/-mice were euthanized with pentobarbital sodium (100 mg/kg, i.p.). The aorta was gently removed after thoracotomy, cleaned of fat and connective tissues, and cut transversely into rings of 3-4 mm in length as described previously by us [5] . Extreme care was taken not to damage the endothelium. The rings were mounted vertically between two stainless steel wire hooks. The two rings were suspended in 10 ml organ baths containing modified Krebs-Henseleit buffer (in 118 mM of NaCl, 4.8 mM of KCl, 1.2 mM of MgSO 4 , 1.2 mM of KH 2 PO 4 , 25 mM of NaHCO 3 , 11 mM of glucose, and 2.5 mM of CaCl 2 ). The buffer was maintained around pH 7.4 at 37°C. The aortic rings were equilibrated for 60 min with a resting force of 1 g as described previously by us [5] . At the end of the equilibration period, tissues were contracted with KCl (50 mM) to check the viability. Aortic rings were then constricted with phenylephrine (PE, 10 -6 M), and changes in tension were monitored continuously with a fixed range precision force transducer (TSD, 125 C, BIOPAC system). Data were recorded using MP100 WSW, BIOPAC digital acquisition system and analyzed using Acknowledge 3.5.7 software (BIOPAC system). The vascular endothelium was tested to determine whether it was intact, as previously described by our laboratory [5] through acetylcholine (ACh, 10 -6 M) on pre-contracted aortic rings with phenylephrine (PE). Preparations were then washed several times with Krebs-Henseleit buffer solution and allowed to equilibrate for 30 min before the experimental protocol began. For all tests, the contraction and relaxation responses are expressed as % decrease or % increase of PE-induced pre-contraction. 
phenethylamino-5 0 -N-ethylcarboxamido adenosine hydrochloride (CGS 21680), or selective PPAR c agonist, Rosiglitazone, were obtained by cumulative addition of these drugs to the organ bath in 1-log increments to obtain a concentration-response curve (CRC) as previously described [28, 29] . All concentration-response determinations were run in parallel on pairs of rings from Selective sEH inhibitor, 12-(3-adamantan-1-yl-ureido)-dodecanoic acid (AUDA; 10 lM), was added 30 min before contraction of the tissue with PE and was present throughout the experiment. These experiments were performed in parallel on four rings from the same aorta with two serving as control and two treated with AUDA.
Effects of K ATP channels inhibitor and A 2A AR antagonist on CGS 21680, Rosiglitazone-induced vascular response in A 2A AR
?/? and A 2A AR -/-mice fed HS and NS Selective K ATP channel inhibitor (Glibenclamide, 10 lM) and selective A 2A AR antagonist (SCH-58261; 1 lM) were added 30 min before contraction of the tissue with PE and were present throughout the experiment. These experiments were performed in parallel on four rings from the same aorta with two serving as control and two treated with Glibenclamide or SCH-58261.
Western blot analysis
Aortae from HS and NS-fed A 2A AR
?/? and A 2A AR -/-mice were isolated, and each sample was homogenized with 130 ll RIPA buffer (Cell Signaling Technology Inc) on wet ice. The samples were transferred to dry ice for 5 min and then thawed on wet ice. After thawing, lysates were sonicated and the samples were vortexed and centrifuged for 5 min at 12,000 rpm at 4°C. Then, the supernatant was stored at -80°C. Protein was measured using Bio-Rad assay based on the Bradford dye procedure with bovine serum albumin (BSA) as a standard. The protein mixture was divided into aliquots and stored at -80°C. At the time of analysis, samples were thawed, and 30 lg of total protein per lane was loaded on a slab gel. Proteins were separated by SDS-PAGE using 10 % acrylamide gels (1-mm thick). After electrophoresis, the proteins on the gel were transferred to nitrocellulose membrane (Hybond-ECL) by electroelution. Protein transfer was confirmed by employing pre-stained molecular weight markers (Bio-Rad Laboratories, Hercules, CA). Following blocking with either 5 % nonfat dry milk or BSA, the nitrocellulose membranes were incubated with primary antibodies for sEH and PPARc (Santa Cruz Biotechnology, Santa Cruz, CA). 1:5000 primary antibody concentration was used for sEH antibody, and 1:1000 primary antibody concentration was used for PPARc antibody. b-actin antibody (Santa Cruz Biotechnology, Santa Cruz, CA) was used as an internal control to normalize the target protein expression in each lane. The secondary antibody was a horseradish peroxidase-conjugated anti-rabbit or antimouse IgG. The membranes were developed using enhanced chemiluminescence (Amersham BioSciences) and exposed to X-ray film for the appropriate time. The data are presented as the ratio of target protein expression to b-actin.
Chemicals, drugs, and antibodies
Phenylephrine hydrochloride and acetylcholine chloride were dissolved in distilled water. NECA, CGS 21680, SCH-58261, Glibenclamide (Sigma Chemicals, St. Louis, MO), Rosiglitazone (Cayman chemicals, Ann Arbor, MI) were dissolved in 100 % DMSO as 10 mM stock solutions, which were followed by serial dilutions in distilled water. T0070907 (Cayman chemicals) and AUDA (gift from Dr. Morisseau, UC Davis) were dissolved in DMSO. sEH (Santa Cruz Biotechnology) was used for Western blot experiments.
Statistical analysis
Statistical data are reported as mean ± SEM. One-way analysis of variance (ANOVA) was used to compare difference among groups and two-way ANOVA for repeated measure, followed by Tukey post hoc test to compare the vascular responses to antagonist SCH-58261, Glibenclamide, AUDA, and T0070907. Differences were considered significant if p \ 0.05. Further, densitometry of Western blot analysis (sEH) data was expressed as mean ± SEM in arbitrary units. All the statistical analyses were performed using Graph Pad Prism statistical package. Fig. 1b) . These results suggest that pharmacological inhibition of sEH using AUDA to increase EETs availability can reverse vascular contraction to NECA in Fig. 1 (Fig. 3) . In Fig. 3 (Fig. 4a) . On the other hand, Rosiglitazone (10 -6 M) produced significant contraction in NS and HS-fed A 2A AR -/-mice (-14.49 ± 2.02 and -18.47 ± 3.48 %; Fig. 4a ), respectively. This interesting finding implies that HS-induced relaxation to Rosiglitazone requires A 2A AR, suggesting a link between A 2A AR and PPARc. Fig. 5 ). There was no change in CGS21680-induced response in NS-fed A 2A AR
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?/? mice with or without Glibenclamide (Fig. 5) .
Similarly, Glibenclamide also blocked Rosiglitazoneinduced vascular relaxation in HS-fed A 2A AR ?/? mice from ?3.50 ± 2.87 to -8.13 ± 1.78 % at 10 -6 M (p \ 0.05; Fig. 6 sEH inhibitor, AUDA, increases or stabilizes the vasoactive EETs [33] . HS produced greater relaxation to CGS 21680 compared to NS diet in A 2A AR ?/? mice (Fig. 2a) . We observed that AUDA enhanced vascular relaxation to NECA in NS-fed wild-type mice (Fig. 1a) to the level shown in HS-fed mice, suggesting that sEH inhibition causes higher relaxation through higher EETs level; however, there was no difference in vascular response to CGS 21680 in HS-fed A 2A AR
?/? mice with AUDA as reported earlier by us [10] .
Cyp-epoxygenase enzyme (cyp2c29) responsible for EETs production is demonstrated to be lower in A 2A AR -/-mice on a HS diet [11] implying possible reduced availability of EETs in A 2A AR-deficient mice. Of note, studies have shown that reduced EETs can impair endothelial dilator response in obesity and diabetes [34, 35] . In HS/NSfed A 2A AR -/-mice, AUDA was able to substantially reverse the NECA-induced vascular contraction (Fig. 1b) , indicating beneficial use of sEH inhibitor in improving impaired vascular reactivity by elevating EETs in HS/NSfed A 2A AR -/-mice. Hence, it is logical that sEH inhibitor provides beneficial effects through elevating EETs which have vasodilatory and natriuretic properties. AUDA treatment has been reported to reduce ischemic infarct size in stroke-prone spontaneously hypertensive rats [36] . Another sEH inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (t-AUCB) is shown to be protective against ischemia reperfusion injury [37] . Moreover, Imig et al. 2005 demonstrated the blood pressure lowering effect in rats with salt-sensitive hypertension and angiotensin II-induced hypertension [13, 38] . Also, we observed higher sEH expression in A 2A AR -/-mice compared to A 2A AR ?/? mice on HS and NS diet (Fig. 7 ) which further contributes to increased EETs conversion into diols (DHETs) in A 2A AR null mice leading to lower EETs level.
A 2A AR-mediated enhanced vascular relaxation in HSfed A 2A AR
?/? mice is dependent on EETs, and EETs are shown to act on PPARc [27] . Therefore, we tested if A 2A AR-elicited vascular relaxation is dependent on PPARc. We found that PPARc antagonist, T0070907, significantly blocked HS-induced relaxation to CGS 21680 (Fig. 2a) , indicating the involvement of PPARc downstream of A 2A AR to produce enhanced vascular relaxation in mice in response to HS diet. This finding is in agreement with our previous published work [39] and others [27, 40] and confirms the contribution of PPARc in A 2A AR-mediated vascular response. Also, AUDA concentration-response curve indirectly represents EETs-dependent vascular response because sEH inhibition increases EETs level [26] . AUDA produced enhanced relaxation in HS-fed A 2A AR
?/? mice compared to NS diet, and this enhanced relaxation was blocked by PPARc antagonist (Fig. 3) suggesting that EETs-mediated vascular relaxation is dependent on PPARc. Altogether, from our results, it became evident that PPARc contributes downstream of A 2A AR and EET to produce greater vascular relaxation upon exposure to HS diet.
Consistent with the presence of PPARc in vascular tissues, substantial evidence suggest the participation of PPARc in regulation of vascular function and blood pressure [41] . PPARc activation is reported to increase blood flow via vasodilation [31, 42] . We examined vascular response to PPARc in HS and NS-fed A 2A AR
?/? and A 2A AR -/-mice using selective PPARc agonist, Rosiglitazone. We found that Rosiglitazone produced significantly greater relaxation in HS compared to NS-fed A 2A AR ?/? mice (Fig. 4a) Supporting the data published in earlier studies from our lab [44] , we found that HS-induced increased vascular relaxation to CGS 21680 is blocked by K ATP channel inhibitor, Glibenclamide (Fig. 5) , indicating the role of K ATP channels in A 2A AR-mediated vascular response. Also, PPARc agonist, Rosiglitazone-elicited enhanced vascular relaxation, was attenuated by Glibenclamide (Fig. 6) , implicating the contribution of K ATP channel in PPARc-mediated vascular relaxation. Taken together, these data suggest that A 2A AR-EETs-PPARc pathway produces vascular relaxation through K ATP channel which is consistent with our earlier reports [10, 39] , suggesting that PPARc elicits relaxation in both mouse vascular and human pulmonary arteries by activating K ATP channels [31] .
PPARc-dependent effects mostly occur through regulation of gene expression. However, these A 2A AR-EETSPPARc-mediated changes in vascular tone through K ATP channels are quick response that could not correlate with changes in gene expression that generally takes longer time. There is some evidence indicating that PPARc-dependent alteration in vascular tone could occur through non-genetic pathway possibly via phosphorylation. Report also suggests that PPARc activation works through rapid ? current [45] , thereby reducing vascular contraction. TZDs may promote vascular relaxation through stimulation of k ca channels; however, the mechanism remains unclear [46] . In addition, Pioglitazone is shown to promote activation of myosin light chain phosphatase [47] and also inhibition of Rho kinase activity in vasculature [48] . Hence, A 2A AR-EETs-mediated vascular relaxation depend on PPARc signaling leading to the opening of K ATP channels, the mechanism of K ATP channels opening may be through non-genomic action of PPARc, and that needs to be further explored. In vitro organ bath data can be extrapolated into in vivo situations under high salt diet-fed conditions in mice by measuring blood pressure in live animals through tail-cuff method or telemetry.
Conclusion
The principle finding of this study identifies important signaling molecules involved in HS-induced altered vascular reactivity to adenosine receptors agonist (NECA) in the presence and absence of A 2A AR. EETs, PPARc, and K ATP channels are recognized as key downstream signaling molecules contributing to HS-induced A 2A AR-mediated vascular relaxation, while increased sEH is identified as essential mediator involved in HS-elicited vascular contraction in A 2A AR null mice (Fig. 8) . Most importantly, our data shed light on possible strategy to reverse HSinduced contraction to adenosine receptors agonist (NECA) observed in A 2A AR null mice by increasing the level of EETs through sEH inhibition.
